Sequence supplied with the lot CoA
CAS 320367-13-3Enhanced verificationMade to order · 2–6 weeks
Lixisenatide
Exendin-4 analogue with C-terminal hexalysine
4858 g/mol · ≥98% (HPLC)
Verified orders. Each order needs institutional verification and a signed end-use statement before it ships. Orders above typical research quantities are reviewed first. Why
About this peptide
Exendin-4 derived GLP-1R agonist with a six-lysine C-terminal extension.
Reported research uses
- 01GLP-1R agonist comparison studies
- 02Gastric-emptying research models
Specifications
- CAS number
- 320367-13-3
- Molecular formula
- C₂₁₅H₃₄₇N₆₁O₆₅S
- Molecular weight
- 4858 g/mol
- Purity
- ≥98% (HPLC)
- Counter-ion
- TFA (acetate on request)
- Appearance
- Lyophilised white powder
- Storage
- −20 °C, desiccated, protected from light
- Synonyms
- AVE0010; ZP10
Values from the manufacturer’s documents and published sources, for reference only; the lot CoA is the reference. Reported uses are from the literature and are not a claim that the product is suitable or safe for any purpose. For laboratory research use only — not for human or veterinary use. Handle only by trained staff following the SDS. Synthesised after your order is verified; MS and HPLC data come with the lot.